Navigation Links
Generex Announces Presentations of Antigen Express AE37 Breast Cancer Vaccine Data at ASCO 2012
Date:5/8/2012

d & Drug Administration (FDA) and move into pivotal Phase III trials.

About Generex Biotechnology Corporation

Generex is engaged in the research, development, and commercialization of drug delivery systems and technologies. Generex has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity (with no deposit in the lungs). The Company's proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using the Company's proprietary RapidMist™ device. Antigen Express, Inc. is a wholly owned subsidiary of Generex. The core platform technologies of Antigen Express comprise immunotherapeutic vaccines for the treatment of malignant, infectious, allergic, and autoimmune diseases. Antigen Express has pioneered the use of specific CD4+ T-helper stimulation in immunotherapy. One of its platform technologies relies on inhibition of expression of the Ii protein. Antigen Express scientists, and others, have shown clearly that suppression of expression of the Ii protein in cancer cells allows for potent stimulation of T-helper cells and prevents the further growth of cancer cells. For more information, visit the Generex website at www.generex.com or the Antigen Express website at www.antigenexpress.com.

Cautionary Note Regarding Forward-Looking Statements

This release and oral statements made from time to time by Generex representatives in respect of the same subject matter may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by introductory words such as "expects," "plan," "believes," "will," "achieve," "anticipate," "would," "should," "subject to" or words of similar m
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Generex Subsidiary Antigen Express Announces Publication of Review Showcasing its Proprietary Therapeutic Vaccine Technology in the Journal Vaccine
2. Generex Subsidiary Antigen Express to Present at Prestigious Cancer Immunotherapy Summit
3. Generex Subsidiary Antigen Express Featured on SNN Stock News Now; Highlights Advantages of Ii-Key Platform Technology for Cancer Immunotherapy
4. Generex Subsidiary Antigen Express Available for Partnering & Collaboration Meetings at the 2012 JPMorgan Healthcare Conference
5. Generex Announces Airing of Antigen Express Breast Cancer Vaccine Segment on Bloomberg Television
6. Generex Provides Update on Bloomberg TV Breast Cancer Vaccine Segment
7. Generex Subsidiary Antigen Express to Present AE37 Cancer Vaccine Phase 2 Clinical Data at 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium
8. Generex Announces Investor Update Conference Call Planned for Late November
9. Generex to Present at the Rodman & Renshaw 13th Annual Healthcare Conference
10. Generex Subsidiary Antigen Express Provides Update on Phase 2 Breast Cancer Immunotherapy Program
11. Generex Provides Corporate Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/6csvbs/market_assessment ... "Market Assessment of Respiratory Diagnostics in the United ... ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,This research service provides ... in the United States ... provides detailed analysis of the current and forecasted ...
(Date:5/21/2015)... REDWOOD CITY, Calif. , May 21, 2015  Cardica, ... 20, 2015, new employee Greg Watson , the company,s ... 400,000 shares of the company,s common stock, at a per ... May 20, 2015. The stock option was granted pursuant to ... board of directors in May 2015 under Rule 5653(c)(4) of ...
(Date:5/21/2015)... YORK , 21. Mai 2015 ... DPRX ), ein Unternehmen für ... auf die Entwicklung und Vermarktung von ... konzentriert, kündigte heute eine wissenschaftliche Posterpräsentation ... Phase-III-Zulassungsstudie des Unternehmens vorstellt, OneStep-1 und ...
Breaking Medicine Technology:United States and Europe Respiratory Diagnostics Market Assessment 2015 2Cardica Announces New Employment Inducement Grant 2Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 2Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 3Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 4Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 5Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 6Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 7
... Direct Factor Xa Inhibitor,Shows a Significant Reduction ... with Enoxaparin with Similarly Low Bleeding,Rates , ... III clinical trial,data presented today at the ... Congress demonstrate that once-daily,rivaroxaban (Xarelto®) achieved superior ...
... Insmed Inc. (NASDAQ:INSM), a ,biopharmaceutical company focused on the ... metabolic diseases with unmet,medical needs, today announced that ... Emerging Growth,Opportunities Conference in New York City. ... Mandarin Oriental Hotel in New,York City, will run ...
Cached Medicine Technology:Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 2Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 3Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 4Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 5Insmed Inc. to Present at C.E. Unterberg, Towbin Growth Conference 2
(Date:5/22/2015)... Hershey, Pa. (PRWEB) May 22, 2015 ... has been selected to participate in the 2015 Congress ... event is described as a gathering of “America’s highest ... about new areas of healthcare, set new goals and ... will include a live surgery, during which we can ...
(Date:5/22/2015)... NY (PRWEB) May 22, 2015 Hands ... that June 17, 2015, the Annual One Day Sale ... Since 2007, Hands On HCMT offers drastically reduced certificates one ... and estheticians have enough sessions, through what used to be ... is wonderful for the community as well. This once a ...
(Date:5/22/2015)... May 22, 2015 Family, friends, students, ... world-renowned surgical oncologist, Dr. LaSalle D. Leffall, on Monday, ... luncheon began after Grand Rounds in the hospital’s Tower ... anxiously outside the auditorium, trying to keep the secret. ... if he sees me, he’ll know something is up,” ...
(Date:5/22/2015)... May 22, 2015 Coordinating care ... difficult process. Historically providers have not been reimbursed ... Starting in 2015, Medicare has paved the way ... Thanks to the launch of Oculus Health ... health systems using the platform will now be ...
(Date:5/22/2015)... According to a new Aegis Living Study ... as likely to worry about what will happen to their ... Boomers, 69% Silent Generation), which may help explain why nearly ... aging, particularly Millennials (47%), Gen X’ers (51%), and Boomers (43%). ... 2015 among more than 2,000 U.S. adults ages 18+. ...
Breaking Medicine News(10 mins):Health News:Milton Hershey School Student Chosen for Congress of Future Medical Leaders 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Announces Their Eighth Annual One Day Sale on Gift Certificates Will Take Place on June 17, 2015 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Announces Their Eighth Annual One Day Sale on Gift Certificates Will Take Place on June 17, 2015 3Health News:Colleagues Surprise Dr. LaSalle Leffall with 85th Birthday Celebration 2Health News:Oculus Health Care Coordination Platform Officially Launched 2Health News:Oculus Health Care Coordination Platform Officially Launched 3Health News:Oculus Health Care Coordination Platform Officially Launched 4Health News:New Study Reveals America’s Fear of Aging 2Health News:New Study Reveals America’s Fear of Aging 3
... ... Today, Is Released to More Distributors in Pennsylvania. LeadConfirm Professional, the first and only ... more doctors and health care professionals in Kansas through a wider distribution base. ... San Diego, CA ...
... PORTLAND, Ore., June 3 Dr. Mark E. Schafer, ... internationally recognized expert in ultrasonic technology, recently presented a ... Meeting of the Acoustical Society of America in Portland, ... intensity focused ultrasound, or HIFU, has driven the need ...
... China, June 2 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical,Inc. ... CSKI ), a leading,fully integrated pharmaceutical company producing ... announced that it obtained,approval from the State Food and ... Sodium eye drops. The document number for the drug ...
... 2 Speaker Nancy Pelosi held a press availability with ... in the Capitol this afternoon. Below are their remarks: ... privilege to welcome the Secretary to the Speaker,s office. Both of ... we,ve had - of course the Secretary went there long after ...
... Andy" Holder Visits Kaheka Pharmacy To Inspire Others to Manage Chronic ... of an inspirational nationwide tour, "Iron Andy" Holder, an Ironman competitor ... in a Wellness Fair at a Don Quijote Pharmacy in Honolulu ... 14-year-old boy with type 1 diabetes, who was inspired by Andy,s ...
... , ORANGE COUNTY, Calif., June 2 Beckman Coulter, Inc. ... marketer of products that simplify, automate, and innovate complex biomedical ... , , (Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO ) , ... 24, 2009, Chicago, Illinois - The American Association for, ...
Cached Medicine News:Health News:Parents In Kansas Can Now Test Their Children For Lead Exposure Using Saliva 2Health News:Parents In Kansas Can Now Test Their Children For Lead Exposure Using Saliva 3Health News:Parents In Kansas Can Now Test Their Children For Lead Exposure Using Saliva 4Health News:Sound Surgical Technologies' Chief Technology Officer Presents Paper on Focused Ultrasound Technology 2Health News:China Sky One Medical, Inc. Obtains SFDA Approval for Diclofenac Sodium Eye Drops 2Health News:China Sky One Medical, Inc. Obtains SFDA Approval for Diclofenac Sodium Eye Drops 3Health News:Pelosi Remarks Before Meeting with Secretary of Health and Human Services Kathleen Sebelius 2Health News:Ironman Competitor with Diabetes Inspires Individuals with Diabetes to Live Without Limits 2Health News:Upcoming Investor Events at The American Association for Clinical Chemistry (AACC) Annual Meeting & Clinical Lab Exposition 2
An injectable IOL, single-use injector for the IOL and post-op protective eye-shield all packaged in one handy, ready-to-use system pack....
... IOL is the newest advance in lens ... patient and surgeon in mind. Its unique ... crosslinked with PMMA haptics to provide superb ... performance and biocompatibility. The high memory lathe-cut ...
Raysoft Foldable Intraocular Lens....
BIGBAG Hydrophilic Acrylic Lens for high myopia....
Medicine Products: